206 related articles for article (PubMed ID: 22278244)
1. An antibody recognizing the apical domain of human transferrin receptor 1 efficiently inhibits the entry of all new world hemorrhagic Fever arenaviruses.
Helguera G; Jemielity S; Abraham J; Cordo SM; Martinez MG; Rodríguez JA; Bregni C; Wang JJ; Farzan M; Penichet ML; Candurra NA; Choe H
J Virol; 2012 Apr; 86(7):4024-8. PubMed ID: 22278244
[TBL] [Abstract][Full Text] [Related]
2. Antibody-Based Inhibition of Pathogenic New World Hemorrhagic Fever Mammarenaviruses by Steric Occlusion of the Human Transferrin Receptor 1 Apical Domain.
Ferrero S; Flores MD; Short C; Vazquez CA; Clark LE; Ziegenbein J; Zink S; Fuentes D; Payes C; Batto MV; Collazo M; García CC; Abraham J; Cordo SM; Rodriguez JA; Helguera G
J Virol; 2021 Aug; 95(17):e0186820. PubMed ID: 34132574
[TBL] [Abstract][Full Text] [Related]
3. Human and host species transferrin receptor 1 use by North American arenaviruses.
Zong M; Fofana I; Choe H
J Virol; 2014 Aug; 88(16):9418-28. PubMed ID: 24920811
[TBL] [Abstract][Full Text] [Related]
4. Vaccine-elicited receptor-binding site antibodies neutralize two New World hemorrhagic fever arenaviruses.
Clark LE; Mahmutovic S; Raymond DD; Dilanyan T; Koma T; Manning JT; Shankar S; Levis SC; Briggiler AM; Enria DA; Wucherpfennig KW; Paessler S; Abraham J
Nat Commun; 2018 May; 9(1):1884. PubMed ID: 29760382
[TBL] [Abstract][Full Text] [Related]
5. Guinea Pig Transferrin Receptor 1 Mediates Cellular Entry of Junín Virus and Other Pathogenic New World Arenaviruses.
Hickerson BT; Westover JB; Wang Z; Lee YM; Gowen BB
J Virol; 2020 Jan; 94(4):. PubMed ID: 31748396
[TBL] [Abstract][Full Text] [Related]
6. Transferrin receptor 1 is a cellular receptor for New World haemorrhagic fever arenaviruses.
Radoshitzky SR; Abraham J; Spiropoulou CF; Kuhn JH; Nguyen D; Li W; Nagel J; Schmidt PJ; Nunberg JH; Andrews NC; Farzan M; Choe H
Nature; 2007 Mar; 446(7131):92-6. PubMed ID: 17287727
[TBL] [Abstract][Full Text] [Related]
7. Host-species transferrin receptor 1 orthologs are cellular receptors for nonpathogenic new world clade B arenaviruses.
Abraham J; Kwong JA; Albariño CG; Lu JG; Radoshitzky SR; Salazar-Bravo J; Farzan M; Spiropoulou CF; Choe H
PLoS Pathog; 2009 Apr; 5(4):e1000358. PubMed ID: 19343214
[TBL] [Abstract][Full Text] [Related]
8. Machupo virus glycoprotein determinants for human transferrin receptor 1 binding and cell entry.
Radoshitzky SR; Longobardi LE; Kuhn JH; Retterer C; Dong L; Clester JC; Kota K; Carra J; Bavari S
PLoS One; 2011; 6(7):e21398. PubMed ID: 21750710
[TBL] [Abstract][Full Text] [Related]
9. Structural basis for receptor recognition by New World hemorrhagic fever arenaviruses.
Abraham J; Corbett KD; Farzan M; Choe H; Harrison SC
Nat Struct Mol Biol; 2010 Apr; 17(4):438-44. PubMed ID: 20208545
[TBL] [Abstract][Full Text] [Related]
10. Receptor determinants of zoonotic transmission of New World hemorrhagic fever arenaviruses.
Radoshitzky SR; Kuhn JH; Spiropoulou CF; Albariño CG; Nguyen DP; Salazar-Bravo J; Dorfman T; Lee AS; Wang E; Ross SR; Choe H; Farzan M
Proc Natl Acad Sci U S A; 2008 Feb; 105(7):2664-9. PubMed ID: 18268337
[TBL] [Abstract][Full Text] [Related]
11. New world clade B arenaviruses can use transferrin receptor 1 (TfR1)-dependent and -independent entry pathways, and glycoproteins from human pathogenic strains are associated with the use of TfR1.
Flanagan ML; Oldenburg J; Reignier T; Holt N; Hamilton GA; Martin VK; Cannon PM
J Virol; 2008 Jan; 82(2):938-48. PubMed ID: 18003730
[TBL] [Abstract][Full Text] [Related]
12. Transferrin receptor 1 in the zoonosis and pathogenesis of New World hemorrhagic fever arenaviruses.
Choe H; Jemielity S; Abraham J; Radoshitzky SR; Farzan M
Curr Opin Microbiol; 2011 Aug; 14(4):476-82. PubMed ID: 21807555
[TBL] [Abstract][Full Text] [Related]
13. Nonhuman transferrin receptor 1 is an efficient cell entry receptor for Ocozocoautla de Espinosa virus.
Caì Y; Yú S; Mazur S; Dong L; Janosko K; Zhang T; Müller MA; Hensley LE; Bavari S; Jahrling PB; Radoshitzky SR; Kuhn JH
J Virol; 2013 Dec; 87(24):13930-5. PubMed ID: 24109228
[TBL] [Abstract][Full Text] [Related]
14. Host receptor-targeted therapeutic approach to counter pathogenic New World mammarenavirus infections.
Hickerson BT; Daniels-Wells TR; Payes C; Clark LE; Candelaria PV; Bailey KW; Sefing EJ; Zink S; Ziegenbein J; Abraham J; Helguera G; Penichet ML; Gowen BB
Nat Commun; 2022 Jan; 13(1):558. PubMed ID: 35091550
[TBL] [Abstract][Full Text] [Related]
15. Computational and Functional Analysis of the Virus-Receptor Interface Reveals Host Range Trade-Offs in New World Arenaviruses.
Kerr SA; Jackson EL; Lungu OI; Meyer AG; Demogines A; Ellington AD; Georgiou G; Wilke CO; Sawyer SL
J Virol; 2015 Nov; 89(22):11643-53. PubMed ID: 26355089
[TBL] [Abstract][Full Text] [Related]
16. Rational design of universal immunotherapy for TfR1-tropic arenaviruses.
Cohen-Dvashi H; Amon R; Agans KN; Cross RW; Borenstein-Katz A; Mateo M; Baize S; Padler-Karavani V; Geisbert TW; Diskin R
Nat Commun; 2020 Jan; 11(1):67. PubMed ID: 31900422
[TBL] [Abstract][Full Text] [Related]
17. Identification of Clotrimazole Derivatives as Specific Inhibitors of Arenavirus Fusion.
Torriani G; Trofimenko E; Mayor J; Fedeli C; Moreno H; Michel S; Heulot M; Chevalier N; Zimmer G; Shrestha N; Plattet P; Engler O; Rothenberger S; Widmann C; Kunz S
J Virol; 2019 Mar; 93(6):. PubMed ID: 30626681
[TBL] [Abstract][Full Text] [Related]
18. Contrasting Modes of New World Arenavirus Neutralization by Immunization-Elicited Monoclonal Antibodies.
Ng WM; Sahin M; Krumm SA; Seow J; Zeltina A; Harlos K; Paesen GC; Pinschewer DD; Doores KJ; Bowden TA
mBio; 2022 Apr; 13(2):e0265021. PubMed ID: 35315691
[TBL] [Abstract][Full Text] [Related]
19. New World arenavirus clade C, but not clade A and B viruses, utilizes alpha-dystroglycan as its major receptor.
Spiropoulou CF; Kunz S; Rollin PE; Campbell KP; Oldstone MB
J Virol; 2002 May; 76(10):5140-6. PubMed ID: 11967329
[TBL] [Abstract][Full Text] [Related]
20. Comparative analysis of disease pathogenesis and molecular mechanisms of New World and Old World arenavirus infections.
McLay L; Liang Y; Ly H
J Gen Virol; 2014 Jan; 95(Pt 1):1-15. PubMed ID: 24068704
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
